Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
195.96
+1.00 (0.51%)
At close: Aug 13, 2025, 4:00 PM
196.07
+0.11 (0.06%)
After-hours: Aug 13, 2025, 7:58 PM EDT
BDX Revenue
Becton, Dickinson and Company had revenue of $5.51B in the quarter ending June 30, 2025, with 10.40% growth. This brings the company's revenue in the last twelve months to $21.39B, up 7.86% year-over-year. In the fiscal year ending September 30, 2024, Becton, Dickinson and Company had annual revenue of $20.18B with 4.16% growth.
Revenue (ttm)
$21.39B
Revenue Growth
+7.86%
P/S Ratio
2.64
Revenue / Employee
$289,000
Employees
74,000
Market Cap
56.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
| Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
| Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BDX News
- 2 days ago - Heartland's 3 Tactical Q2 Moves: Trimming Risk, Harvesting Losses, And Raising Cash - Seeking Alpha
- 6 days ago - Becton Dickinson Q3 Beats Estimates On Medical Device Boom - Benzinga
- 6 days ago - Becton, Dickinson and Company (BDX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Becton Dickinson joins peer in raising annual profit forecast after results beat - Reuters
- 6 days ago - BD Reports Third Quarter Fiscal 2025 Financial Results - PRNewsWire
- 8 days ago - BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories - PRNewsWire
- 9 days ago - BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care - PRNewsWire
- 13 days ago - BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home - PRNewsWire